Niki BioSolutions annual free cash flow
2017
2018
2019
2020
2021
2022
2023
Niki BioSolutions Free Cash Flow (FCF) History (NIKI)
Niki BioSolutions reported −$7.7M in free cash flow for fiscal 2023, an increase of $4.8M from the previous fiscal year, with a free cash flow margin of −1791.32%.
View full Niki BioSolutions company overviewNiki BioSolutions free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$7.7M | $4.8M | — | −1791.32% |
| 2022 | 2022-12-31 | −$12.5M | $2.3M | — | −965.04% |
| 2021 | 2021-12-31 | −$14.8M | $1.3M | — | −958.85% |
| 2020 | 2020-12-31 | −$16.1M | −$1.9M | — | — |
| 2019 | 2019-12-31 | −$14.2M | $1.5M | — | — |
| 2018 | 2018-12-31 | −$15.7M | −$7.8M | — | — |
| 2017 | 2017-12-31 | −$7.9M | — | — | — |
Niki BioSolutions quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Niki BioSolutions free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$15.7M to −$7.7M, a net increase of $8.0M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Niki BioSolutions filings at SEC.gov ↗